177 related articles for article (PubMed ID: 30085099)
21. Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy.
Ponnusamy S; Sullivan RD; You D; Zafar N; He Yang C; Thiyagarajan T; Johnson DL; Barrett ML; Koehler NJ; Star M; Stephenson EJ; Bridges D; Cormier SA; Pfeffer LM; Narayanan R
Hum Mol Genet; 2017 Jul; 26(13):2526-2540. PubMed ID: 28453658
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Dystrophic
Addinsall AB; Forgan LG; McRae NL; Kelly RW; McDonald PL; McNeill B; McCulloch DR; Stupka N
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32156081
[TBL] [Abstract][Full Text] [Related]
23. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
[TBL] [Abstract][Full Text] [Related]
24. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT
Am J Pathol; 2015 Oct; 185(10):2668-84. PubMed ID: 26435413
[TBL] [Abstract][Full Text] [Related]
25. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice.
Wehling M; Spencer MJ; Tidball JG
J Cell Biol; 2001 Oct; 155(1):123-31. PubMed ID: 11581289
[TBL] [Abstract][Full Text] [Related]
26. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
[TBL] [Abstract][Full Text] [Related]
27. Divergent impact of Toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophy.
Mojumdar K; Giordano C; Lemaire C; Liang F; Divangahi M; Qureshi ST; Petrof BJ
J Pathol; 2016 May; 239(1):10-22. PubMed ID: 26800321
[TBL] [Abstract][Full Text] [Related]
28. The role of Notch signaling in muscle progenitor cell depletion and the rapid onset of histopathology in muscular dystrophy.
Mu X; Tang Y; Lu A; Takayama K; Usas A; Wang B; Weiss K; Huard J
Hum Mol Genet; 2015 May; 24(10):2923-37. PubMed ID: 25678553
[TBL] [Abstract][Full Text] [Related]
29. Lack of the serum- and glucocorticoid-inducible kinase SGK1 improves muscle force characteristics and attenuates fibrosis in dystrophic mdx mouse muscle.
Steinberger M; Föller M; Vogelgesang S; Krautwald M; Landsberger M; Winkler CK; Kasch J; Füchtbauer EM; Kuhl D; Voelkl J; Lang F; Brinkmeier H
Pflugers Arch; 2015 Sep; 467(9):1965-74. PubMed ID: 25394886
[TBL] [Abstract][Full Text] [Related]
30. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
[TBL] [Abstract][Full Text] [Related]
31. The nSMase2/Smpd3 gene modulates the severity of muscular dystrophy and the emotional stress response in mdx mice.
Matsuzaka Y; Tanihata J; Ooshima Y; Yamada D; Sekiguchi M; Miyatake S; Aoki Y; Terumitsu M; Yashiro R; Komaki H; Ishiyama A; Oya Y; Inoue YU; Inoue T; Takeda S; Hashido K
BMC Med; 2020 Nov; 18(1):343. PubMed ID: 33208172
[TBL] [Abstract][Full Text] [Related]
32. Changes in calsequestrin, TNF-α, TGF-β and MyoD levels during the progression of skeletal muscle dystrophy in mdx mice: a comparative analysis of the quadriceps, diaphragm and intrinsic laryngeal muscles.
Barros Maranhão J; de Oliveira Moreira D; Maurício AF; de Carvalho SC; Ferretti R; Pereira JA; Santo Neto H; Marques MJ
Int J Exp Pathol; 2015 Oct; 96(5):285-93. PubMed ID: 26515458
[TBL] [Abstract][Full Text] [Related]
33. Restoration of pharyngeal dilator muscle force in dystrophin-deficient (mdx) mice following co-treatment with neutralizing interleukin-6 receptor antibodies and urocortin 2.
Burns DP; Rowland J; Canavan L; Murphy KH; Brannock M; O'Malley D; O'Halloran KD; Edge D
Exp Physiol; 2017 Sep; 102(9):1177-1193. PubMed ID: 28665499
[TBL] [Abstract][Full Text] [Related]
34. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
35. A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1.
Xu D; Zhao L; Jiang J; Li S; Sun Z; Huang X; Li C; Wang T; Sun L; Li X; Jiang Z; Zhang L
J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1306-1320. PubMed ID: 32869445
[TBL] [Abstract][Full Text] [Related]
36. Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice.
Wada E; Tanihata J; Iwamura A; Takeda S; Hayashi YK; Matsuda R
Skelet Muscle; 2017 Oct; 7(1):23. PubMed ID: 29078808
[TBL] [Abstract][Full Text] [Related]
37. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
Palladino M; Gatto I; Neri V; Straino S; Smith RC; Silver M; Gaetani E; Marcantoni M; Giarretta I; Stigliano E; Capogrossi M; Hlatky L; Landolfi R; Pola R
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2867-76. PubMed ID: 24072696
[TBL] [Abstract][Full Text] [Related]
38. Muscle ERRγ mitigates Duchenne muscular dystrophy via metabolic and angiogenic reprogramming.
Matsakas A; Yadav V; Lorca S; Narkar V
FASEB J; 2013 Oct; 27(10):4004-16. PubMed ID: 23781095
[TBL] [Abstract][Full Text] [Related]
39. PDGFRα signalling promotes fibrogenic responses in collagen-producing cells in Duchenne muscular dystrophy.
Ieronimakis N; Hays A; Prasad A; Janebodin K; Duffield JS; Reyes M
J Pathol; 2016 Dec; 240(4):410-424. PubMed ID: 27569721
[TBL] [Abstract][Full Text] [Related]
40. Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy.
Bozycki L; Łukasiewicz K; Matryba P; Pikula S
Skelet Muscle; 2018 Jul; 8(1):21. PubMed ID: 30025544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
